Steven J. Rosansky

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Christopher T. Chan, Peter J. Blankestijn, Laura M. Dember et al. · Kidney International · 2019 · 404 citations · Full text

Hemodialysis, Renal Disease, Health Policy +13

The Calcimimetic AMG 073 as a Potential Treatment for Secondary Hyperparathyroidism of End-Stage Renal Disease

L. Darryl Quarles, Donald J. Sherrard, Stephen Adler et al. · Journal of the American Society of Nephrology · 2003 · 247 citations

Renal Pathology, Parathyroid Disease, Parathyroid Gland +17

Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD

Daniel W. Coyne, Muralidhar Acharya, Ping Qiu et al. · American Journal of Kidney Diseases · 2006 · 226 citations

Secondary Hyperparathyroidism, Urology, Stages 3 +4

Assessment of the Efficacy and Safety of Intravenous Conivaptan in Euvolemic and Hypervolemic Hyponatremia

David Zeltser, Steven J. Rosansky, Hannes van Rensburg et al. · American Journal of Nephrology · 2007 · 212 citations

Early Start of Hemodialysis May Be Harmful

Steven J. Rosansky, Paul W. Eggers, Kirby L. Jackson et al. · Archives of Internal Medicine · 2010 · 165 citations